MedMira Inc (MIR) - Net Assets

Latest as of January 2026: CA$-24.03 Million CAD ≈ $-17.38 Million USD

Based on the latest financial reports, MedMira Inc (MIR) has net assets worth CA$-24.03 Million CAD (≈ $-17.38 Million USD) as of January 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$3.58 Million ≈ $2.59 Million USD) and total liabilities (CA$27.61 Million ≈ $19.97 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MedMira Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CA$-24.03 Million
% of Total Assets -671.74%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

MedMira Inc - Net Assets Trend (2000–2025)

This chart illustrates how MedMira Inc's net assets have evolved over time, based on quarterly financial data. Also explore MIR current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for MedMira Inc (2000–2025)

The table below shows the annual net assets of MedMira Inc from 2000 to 2025. For live valuation and market cap data, see market cap of MedMira Inc.

Year Net Assets Change
2025-07-31 CA$-22.56 Million
≈ $-16.32 Million		 -25.08%
2024-07-31 CA$-18.04 Million
≈ $-13.05 Million		 -19.99%
2023-07-31 CA$-15.03 Million
≈ $-10.87 Million		 -21.65%
2022-07-31 CA$-12.36 Million
≈ $-8.94 Million		 +21.42%
2021-07-31 CA$-15.72 Million
≈ $-11.37 Million		 -1.04%
2020-07-31 CA$-15.56 Million
≈ $-11.26 Million		 -15.13%
2019-07-31 CA$-13.52 Million
≈ $-9.78 Million		 -18.59%
2018-07-31 CA$-11.40 Million
≈ $-8.25 Million		 -26.86%
2017-07-31 CA$-8.98 Million
≈ $-6.50 Million		 -17.26%
2016-07-31 CA$-7.66 Million
≈ $-5.54 Million		 +0.55%
2015-07-31 CA$-7.70 Million
≈ $-5.57 Million		 -15.16%
2014-07-31 CA$-6.69 Million
≈ $-4.84 Million		 +26.57%
2013-07-31 CA$-9.11 Million
≈ $-6.59 Million		 -4.62%
2012-07-31 CA$-8.71 Million
≈ $-6.30 Million		 +54.44%
2011-07-31 CA$-19.11 Million
≈ $-13.83 Million		 -14.70%
2010-07-31 CA$-16.66 Million
≈ $-12.05 Million		 -4.17%
2009-07-31 CA$-16.00 Million
≈ $-11.57 Million		 -14.75%
2008-07-31 CA$-13.94 Million
≈ $-10.08 Million		 -9.10%
2007-07-31 CA$-12.78 Million
≈ $-9.24 Million		 -58.82%
2006-07-31 CA$-8.05 Million
≈ $-5.82 Million		 +17.94%
2005-07-31 CA$-9.80 Million
≈ $-7.09 Million		 -66.92%
2004-07-31 CA$-5.87 Million
≈ $-4.25 Million		 -168.64%
2003-07-31 CA$-2.19 Million
≈ $-1.58 Million		 +70.64%
2002-07-31 CA$-7.45 Million
≈ $-5.39 Million		 -23.98%
2001-07-31 CA$-6.01 Million
≈ $-4.35 Million		 -83.24%
2000-07-31 CA$-3.28 Million
≈ $-2.37 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to MedMira Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 10026146100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (July 2025)

Component Amount Percentage
Other Components CA$83.25 Million %
Total Equity CA$-22.56 Million 100.00%

MedMira Inc Competitors by Market Cap

The table below lists competitors of MedMira Inc ranked by their market capitalization.

Company Market Cap
K Wave Media Ltd.
NASDAQ:KWM
 $30.27 Million
JSW Pacific
TWO:5251
 $30.29 Million
TBH Global Co Ltd
KO:084870
 $30.29 Million
Halcyon Technology Public Company Limited
BK:HTECH
 $30.30 Million
Catcha Digital Bhd
KLSE:0173
 $30.26 Million
Cosol Ltd
AU:COS
 $30.26 Million
Unisync Corp
TO:UNI
 $30.26 Million
Coal Energy S.A.
WAR:CLE
 $30.25 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MedMira Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -18,036,605 to -22,561,012, a change of -4,524,407.
  • Net loss of 4,524,407 reduced equity.
  • Other factors decreased equity by 0.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CA$-4.52 Million -20.05%
Total Change CA$- %

Book Value vs Market Value Analysis

This analysis compares MedMira Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2000-07-31 CA$-0.16 CA$0.06 x
2001-07-31 CA$-0.29 CA$0.06 x
2002-07-31 CA$-0.36 CA$0.06 x
2003-07-31 CA$-0.09 CA$0.06 x
2004-07-31 CA$-0.14 CA$0.06 x
2005-07-31 CA$-0.22 CA$0.06 x
2006-07-31 CA$-0.17 CA$0.06 x
2007-07-31 CA$-0.21 CA$0.06 x
2008-07-31 CA$-0.17 CA$0.06 x
2009-07-31 CA$-0.14 CA$0.06 x
2010-07-31 CA$-0.09 CA$0.06 x
2011-07-31 CA$-0.09 CA$0.06 x
2012-07-31 CA$-0.02 CA$0.06 x
2013-07-31 CA$-0.02 CA$0.06 x
2014-07-31 CA$-0.01 CA$0.06 x
2015-07-31 CA$-0.01 CA$0.06 x
2016-07-31 CA$-0.01 CA$0.06 x
2017-07-31 CA$-0.01 CA$0.06 x
2018-07-31 CA$-0.02 CA$0.06 x
2019-07-31 CA$-0.02 CA$0.06 x
2020-07-31 CA$-0.02 CA$0.06 x
2021-07-31 CA$-0.02 CA$0.06 x
2022-07-31 CA$-0.02 CA$0.06 x
2023-07-31 CA$-0.02 CA$0.06 x
2024-07-31 CA$-0.03 CA$0.06 x
2025-07-31 CA$-0.03 CA$0.06 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MedMira Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1881.18%
  • • Asset Turnover: 0.07x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2000 0.00% -3694.04% 0.02x 0.00x CA$-2.57 Million
2001 0.00% -1925.81% 0.12x 0.00x CA$-6.60 Million
2002 0.00% -4935.31% 0.03x 0.00x CA$-4.91 Million
2003 0.00% -392.35% 0.50x 0.00x CA$-4.40 Million
2004 0.00% -163.71% 1.44x 0.00x CA$-3.41 Million
2005 0.00% -229.51% 1.86x 0.00x CA$-5.13 Million
2006 0.00% -348.46% 0.52x 0.00x CA$-6.48 Million
2007 0.00% -368.70% 0.60x 0.00x CA$-5.01 Million
2008 0.00% -460.34% 1.83x 0.00x CA$-5.62 Million
2009 0.00% -462.64% 2.17x 0.00x CA$-3.66 Million
2010 0.00% -411.74% 1.89x 0.00x CA$-2.75 Million
2011 0.00% -537.68% 0.61x 0.00x CA$-2.98 Million
2012 0.00% 347.43% 0.33x 0.00x CA$4.24 Million
2013 0.00% -20.10% 1.72x 0.00x CA$508.76K
2014 0.00% -151.70% 1.37x 0.00x CA$-3.17 Million
2015 0.00% -79.70% 2.27x 0.00x CA$-2.46 Million
2016 0.00% -228.57% 2.59x 0.00x CA$-4.39 Million
2017 0.00% -356.07% 1.11x 0.00x CA$-1.76 Million
2018 0.00% -426.15% 1.96x 0.00x CA$-1.37 Million
2019 0.00% -399.37% 2.09x 0.00x CA$-754.75K
2020 0.00% -222.55% 0.27x 0.00x CA$-489.15K
2021 0.00% -31.51% 0.55x 0.00x CA$896.59K
2022 0.00% -192.37% 0.25x 0.00x CA$-595.98K
2023 0.00% -618.61% 0.12x 0.00x CA$-1.17 Million
2024 0.00% -806.25% 0.07x 0.00x CA$-1.52 Million
2025 0.00% -1881.18% 0.07x 0.00x CA$-2.27 Million

Industry Comparison

This section compares MedMira Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $24,209,535
  • Average return on equity (ROE) among peers: -379.23%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MedMira Inc (MIR) CA$-24.03 Million 0.00% N/A $30.27 Million
Appili Therapeutics Inc (APLI) $-13.40 Million 0.00% 0.00x $1.86 Million
Aptose Biosciences Inc (APS) $7.33 Million -189.11% 0.18x $4.36 Million
Arch Biopartners Inc (ARCH) $1.06 Million -79.15% 0.19x $20.88 Million
Biomind Labs Inc (BMND) $-1.30 Million 0.00% 0.00x $6.98 Million
Cybin Inc (CYBN) $237.20 Million -47.70% 0.09x $301.37 Million
Eupraxia Pharmaceuticals Inc (EPRX) $1.18 Million -3177.89% 21.71x $393.86 Million
Devonian Health Group Inc (GSD) $14.25 Million -32.28% 0.35x $20.01 Million
Helix BioPharma Corp. (HBP) $-1.39 Million 0.00% 0.00x $116.58 Million
Hemostemix Inc (HEM) $-6.77 Million 0.00% 0.00x $8.18 Million
Universal Ibogaine Inc (IBO) $3.94 Million -266.20% 0.60x $1.13 Million

About MedMira Inc

V:MIR Canada Biotechnology
Market Cap
$30.27 Million
CA$41.85 Million CAD
Market Cap Rank
#23689 Global
#886 in Canada
Share Price
CA$0.06
Change (1 day)
+9.09%
52-Week Range
CA$0.06 - CA$0.10
All Time High
CA$0.70
Categories
Companies in Canada Biotechnology
About

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or who… Read more